Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 15, 2017 09:00 ET | Source: Aduro Biotech, Inc.

Aduro Biotech to Host Research and Development Day in New York

BERKELEY, Calif., March 15, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that the Aduro management team will host a Research and Development Day in New York City, New...
March 10, 2017 09:00 ET | Source: Aduro Biotech, Inc.

Aduro Biotech Awarded East Bay Innovation Award for its Contributions in Life Sciences and the San Francisco East Bay Community

BERKELEY, Calif., March 10, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, announced today the receipt of the...
March 06, 2017 16:05 ET | Source: Aduro Biotech, Inc.

Aduro Biotech Announces Upcoming Data Presentations at the 2017 American Association for Cancer Research Annual Meeting

BERKELEY, Calif., March 06, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, announced data presentations...
March 02, 2017 16:05 ET | Source: Aduro Biotech, Inc.

Aduro Biotech Announces Upcoming Data Presentations at the Keystone Symposia on Cancer Immunology and Immunotherapy Conference

BERKELEY, Calif., March 02, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, today announced data presentations...
March 01, 2017 16:05 ET | Source: Aduro Biotech, Inc.

Aduro Biotech Announces Fourth Quarter and Full Year 2016 Financial Results

-Progress in 2016 Has Positioned the Company to Have Six Agents in the Clinic for Eight Different Cancer Types- BERKELEY, Calif., March 01, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc....
February 28, 2017 08:00 ET | Source: Aduro Biotech, Inc.

Aduro Biotech to Present at Two Investor Conferences in March

BERKELEY, Calif., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that it will present at two investor conferences in March 2017. On Monday, March 6, 2017 at 4:40...
February 10, 2017 08:00 ET | Source: Aduro Biotech, Inc.

Aduro Biotech to Present at the Leerink Partners 6th Annual Global Healthcare Conference

BERKELEY, Calif., Feb. 10, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present...
January 26, 2017 08:00 ET | Source: Aduro Biotech, Inc.

Aduro Biotech Announces Appointment of Leading Immunotherapy and Oncology Experts to Scientific Advisory Board

BERKELEY, Calif., Jan. 26, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, announced today the appointment of...
January 19, 2017 08:00 ET | Source: Aduro Biotech, Inc.

Aduro Biotech Enters into Exclusive License Agreement for Proprietary Neoantigen Identification Technology

BERKELEY, Calif., Jan. 19, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, today announced an exclusive...
January 09, 2017 08:00 ET | Source: Aduro Biotech, Inc.

Aduro Biotech Announces Clinical Collaboration with Merck to Evaluate the Combination of Aduro’s CRS-207 with Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Gastric Cancer

BERKELEY, Calif., Jan. 09, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, announced today a clinical...